You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The changes follow a strategic review and are part of the company's previously announced plans for growing its revenues and reducing costs.
In PNAS this week: role of USF2 in refractory rheumatoid arthritis, thymus-associated cells may show up post-thymectomy in myasthenia gravis patients, and more.
Ambry will provide RNA sequencing for Scipher's PrismRA blood test to predict response to TNF inhibitor therapies in rheumatoid arthritis patients.
The gene expression test retrospectively identified rheumatoid arthritis patients significantly less likely to respond to TNF inhibitor therapy.
A pre-flare-up transcriptional profile in the blood led the team to a group of "pre-inflammation mesenchymal," or PRIME, cells in rheumatoid arthritis.
In January a federal court unsealed a False Claims Act suit from an industry insider that alleges a Myriad subsidiary engaged in a fraudulent kickback scheme.
In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.
The alliance will initially focus on rheumatoid arthritis using biomarkers discovered using Nimble's human proteome immunoprofiling technology.
The company plans to use the funds to fuel its diagnostic development work, focused on predicting drug response in various autoimmune diseases.
The company has raised $30 million to date to fund development and commercialization of its molecular diagnostic test to predict response to anti-TNF therapies.
Moderna reports its vaccine is effective against new SARS-CoV-2 strains, though it is also developing a booster, according to the New York Times.
NPR reports Merck is halting the development of its two candidate SARS-CoV-2 vaccines following disappointing Phase 1 results.
In PLOS this week: gene mutation linked to inherited venous thrombosis, lncRNA patterns in the Asian tiger mosquito, and more.
The Wall Street Journal reports on gaps in COVID-19 testing affecting less affluent urban areas and rural locations.